Cell to Cure ApS
39401975ActiveClinical-stage biopharmaceutical company developing off-the-shelf mesenchymal stem cell therapies for regenerative medicine.
Overview
- 4
- Employees
- Unknown
- Revenue
- 2018
- Founded
Key Decision Makers
Annette Ekblond
Director of Product Development & Qualified Person
Mandana Haack-Sørensen
Director of Manufacturing
Jens Kastrup
CEO & Clinical Director
Martin Roland Jensen
Commercial Director
+1 more contacts in Funnelfeedr
Description
Cell to Cure ApS is a Danish clinical-stage biopharmaceutical company specializing in the development of allogeneic adipose tissue-derived mesenchymal stromal/stem cell therapies. Founded as a spinout from the Cardiology Stem Cell Centre at Rigshospitalet, the company focuses on creating off-the-sh...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- APS
- VAT Number
- DK39401975
Decision Makers
5 contacts in FunnelfeedrAnnette Ekblond
Director of Product Development & Qualified Person
Mandana Haack-Sørensen
Director of Manufacturing
Jens Kastrup
CEO & Clinical Director
Martin Roland Jensen
Commercial Director
Anders Østergaard
Chairman of the Board
Similar Companies
20 similar companies in FunnelfeedrBIOFARMA LOGISTIK A/S
55 employeesInnovative logistics and warehousing solutions for the Nordic pharmaceutical market.
2cureX A/S
4 employeesImproving cancer patient outcomes through individualized 3D drug sensitivity profiling.
NextCell Sverige AB
0 employeesDeveloping revolutionary stem cell therapies for autoimmune diseases.
Boost Pharma Aps Filial
0 employeesDeveloping first-in-class stem cell therapy for brittle bone disease.
ASCENDIS PHARMA A/S
629 employeesGlobal biopharmaceutical company developing innovative therapies using proprietary TransCon technology.
Browse More
Cell to Cure ApS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo